Vestmark Advisory Solutions’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$464K	Sell	1,852 -1,822	-50%	-$453K	0.01%	1080
2025 Q4	$1.01M	Buy	3,674 +2,545	+225%	+$696K	0.01%	791
2025 Q3	$296K	Sell	1,129 -134	-11%	-$32.6K	0.01%	789
2025 Q2	$276K	Sell	1,263 -1,547	-55%	-$331K	﹤0.01%	707
2025 Q1	$629K	Buy	2,810 +1,172	+72%	+$323K	0.02%	485
2024 Q4	$537K	Buy	1,638 +214	+15%	+$67.3K	0.02%	401
2024 Q3	$427K	Buy	1,424 +265	+23%	+$81.2K	0.02%	399
2024 Q2	$382K	Sell	1,159 -104	-8%	-$36.8K	0.02%	431
2024 Q1	$500K	Buy	1,263 +26	+2%	+$9.62K	0.02%	385
2023 Q4	$436K	Buy	1,237 +417	+51%	+$148K	0.02%	361
2023 Q3	$308K	Sell	820 -7,692	-90%	-$2.97M	0.02%	342
2023 Q2	$3.26M	Buy	8,512 +1	+0%	+$357	0.12%	213
2023 Q1	$2.95M	Buy	8,511 +1,972	+30%	+$576K	0.13%	216
2022 Q4	$1.54M	Buy	6,539 +134	+2%	+$31.8K	0.08%	320
2022 Q3	$1.58M	Buy	6,405 +424	+7%	+$129K	0.09%	297
2022 Q2	$1.81M	Buy	5,981 +243	+4%	+$79.1K	0.1%	258
2022 Q1	$2.36M	Buy	5,738 +694	+14%	+$272K	0.13%	206
2021 Q4	$2.37M	Buy	5,044 +210	+4%	+$90.4K	0.13%	192
2021 Q3	$2.05M	Buy	4,834 +537	+12%	+$226K	0.14%	192
2021 Q2	$1.54M	Buy	4,297 +270	+7%	+$89.2K	0.11%	234
2021 Q1	$1.14M	Buy	4,027 +1,074	+36%	+$307K	0.1%	264
2020 Q4	$837K	Buy	2,953 +337	+13%	+$94.6K	0.09%	268
2020 Q3	$719K	Buy	2,616 +208	+9%	+$55K	0.1%	268
2020 Q2	$547K	Buy	2,408 +307	+15%	+$60.3K	0.08%	284
2020 Q1	$320K	Buy	+2,101	New	+$323K	0.06%	348
2019 Q4	–	Sell	-2,126	Closed	-$302K	–	526
2019 Q3	$302K	Sell	2,126 -12	-0.6%	-$1.65K	0.05%	407
2019 Q2	$268K	Buy	2,138 +246	+13%	+$29K	0.05%	435
2019 Q1	$208K	Buy	+1,892	New	+$197K	0.04%	494